View : 174 Download: 34
False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma
- False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma
- Paek S.H.; Kim B.S.; Kang K.H.; Kim H.S.
- Ewha Authors
- Issue Date
- Journal Title
- World Journal of Surgical Oncology
- World Journal of Surgical Oncology vol. 15, no. 1
- BRAF; False-negative rate; Fine-needle aspiration cytology; Papillary thyroid carcinoma
- BioMed Central Ltd.
- SCIE; SCOPUS
- Document Type
- Background: The BRAF V600E mutation is highly specific for papillary thyroid carcinoma (PTC). A test for this mutation can increase the diagnostic accuracy of fine-needle aspiration cytology (FNAC), but a considerably high false-negative rate for the BRAF V600E mutation on FNAC has been reported. In this study, we investigated the risk factors associated with false-negative BRAF V600E mutation results on FNAC. Methods: BRAF V600E mutation results of 221 PTC nodules between December 2011 and June 2013 were retrospectively reviewed. BRAF V600E mutation results on both preoperative FNAC and postoperative formalin-fixed, paraffin-embedded (FFPE) samples were compared. We investigated the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of BRAF V600E mutation results on FNAC. And, we identified the risk factors associated with false-negative results. Results: Of 221 PTC nodules, 150 (67.9%) on FNAC and 185 (83.7%) on FFPE samples were BRAF V600E mutation positive. The sensitivity, specificity, PPV, and NPV for BRAF V600E mutation testing with FNAC were 80.5, 97.2, 99.3, and 49.3%, respectively. Thirty-six (16.3%) BRAF V600E mutation-negative nodules on FNAC were mutation positive on FFPE sample analysis. Risk factors for these false-negative results were age, indeterminate FNAC results (nondiagnostic, atypia of undetermined significance (AUS), and findings suspicious for PTC), and PTC subtype. Conclusion: False-negative rate of BRAF mutation testing with FNAC for thyroid nodules is increased in cases of old age, indeterminate FNAC pathology results, and certain PTC subtypes. Therapeutic surgery can be considered for these cases. A well-designed prospective study with informed consent of patients will be essential for more informative results. © 2017 The Author(s).
- Appears in Collections:
- 의료원 > 의료원 > Journal papers
- Files in This Item:
False-negative BRAF.pdf(293.82 kB)
- RIS (EndNote)
- XLS (Excel)
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.